戻る Agenda
Session 21: Interactions with FDA - Part 1
Session Chair(s)
Elliott Berger, PHD, MS
President
ETB Regulatory Consulting, United States
- Communications with FDA
- Formal Meetings with FDA
- Time Course of Events in Requesting and Preparing for a Meeting >
- Objectives and Conduct of Specific Meetings with FDA